Increased HDL cholesterol and apoA-I in humans and mice treated with a novel SR-BI inhibitor. [electronic resource]
Producer: 20091203Description: 2054-60 p. digitalISSN:- 1524-4636
- Aged
- Animals
- Apolipoprotein A-I -- blood
- Atherosclerosis -- blood
- Cholesterol Ester Transfer Proteins -- blood
- Cholesterol Esters -- blood
- Cholesterol, HDL -- blood
- Diet, Atherogenic
- Double-Blind Method
- Female
- Humans
- Lipoproteins, HDL -- blood
- Liver -- metabolism
- Male
- Mice
- Mice, Inbred C57BL
- Mice, Inbred DBA
- Mice, Knockout
- Mice, Transgenic
- Middle Aged
- Phenylenediamines -- pharmacology
- Protein Kinase Inhibitors -- pharmacology
- Receptors, LDL -- deficiency
- Scavenger Receptors, Class B -- antagonists & inhibitors
- Sulfonamides -- pharmacology
- p38 Mitogen-Activated Protein Kinases -- antagonists & inhibitors
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.